Skip to content

Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy

UFPTI 1431 - HL02: Investigating Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Survivors Treated With Either Photon or Proton Radiation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02404818
Enrollment
5
Registered
2015-04-01
Start date
2015-04-30
Completion date
2021-04-14
Last updated
2022-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hodgkin's Lymphoma

Keywords

Radiation, Cardiac, Hodgkin's lymphoma

Brief summary

The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.

Interventions

PROCEDURECardiac Magnetic Resonance Imaging

A cardiac MRI will be performed.

PROCEDUREEchocardiogram

An echocardiogram will be performed for the following information: M-mode, two-dimensional, Doppler blood flow measurements, and longitudinal strain and strain rate imaging

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Completed radiation and chemotherapy treatment for Hodgkin lymphoma involving the mediastinum. * Patient must be ≥ 18 years at time of consent.

Exclusion criteria

* Pregnant women at time of Cardiac MRI * Contraindications to Cardiac MRI (contrast allergy, metal implants, medical devices) * Glomerular filtration rate (GFR) \< 30, unless approved by Radiologist (UF Health Jacksonville Radiology Policy: Administration of Gadolinium-Based Contrast Agents).

Design outcomes

Primary

MeasureTime frame
Cardiac Abnormalities As Measured By Cardiac MRIDay 1
Cardiac Abnormalities As Measured By EchocardiogramDay 1

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026